A 2026 Yale analysis shows healthy diets combined with exercise consistently reduce epigenetic age, while over-the-counter supplements show limited effects.
In August 2026, Yale University researchers published an analysis in Nature Medicine demonstrating that healthy dietary patterns combined with regular exercise consistently reduced epigenetic age. The study also revealed that over-the-counter supplements had limited or mixed effects on these biological aging markers.
The Yale-led research examined whether specific interventions reliably change biological-age biomarkers in human subjects. The team built the TranslAGE database by combining data from 51 longitudinal human intervention studies. The study’s purpose was not to prove that any specific intervention extends human lifespan. Instead, researchers wanted to determine which aging biomarkers respond reliably enough to be useful in future clinical trials.
They calculated results across 16 prominent epigenetic clocks and 94 additional DNA-methylation biomarkers. This created an extensive panel of more than 110 markers. Yale describes these measurements as blood-based tests. These blood tests estimate biological or epigenetic age from patterns of methyl groups attached to DNA.
The analysis divided these varied interventions into lifestyle changes, prescription drugs, over-the-counter supplements and medical procedures. A report on the findings noted that 19 of the 51 interventions significantly decreased epigenetic age across the biomarker panel before multiple-testing correction. That number fell to 13 interventions after correction. Meanwhile, 26 showed no significant effect in either direction and five actually increased epigenetic age.
The study also found that participant characteristics and the length of an intervention influenced how strongly DNA-methylation biomarkers responded. The analysis revealed that the most responsive clocks were those trained to estimate mortality risk or the pace of aging. Clocks that simply tracked chronological age showed less dramatic changes during the observed intervention periods.
Lifestyle changes produced clear signals when healthy eating was paired with physical activity. Yale specifically identified Mediterranean, low-carbohydrate and low-fat dietary patterns as interventions that consistently decreased epigenetic-age measures alongside exercise.
Prescription treatments produced the strongest overall biomarker responses in the entire analysis. Yale highlighted metabolic medications like metformin and semaglutide alongside anti-inflammatory anti-TNF therapies.
The results for over-the-counter supplements were substantially less consistent across the analyzed data. The Yale analysis found little or inconsistent epigenetic-age effect from the non-prescription supplements it examined. A separate older-adult trial summary did report modest epigenetic-clock changes with omega-3, vitamin D and exercise. That specific finding involved additive effects when these were combined, but the broader Yale analysis did not support a universal supplement strategy.
For longevity researchers, these findings offer a new way to measure the impact of potential therapies. First author Raghav Sehgal noted that researchers have shown for the first time that certain therapies have measurable effects on aging biomarkers. If these newer biomarkers are validated as predictors of long-term health, they could reshape the clinical trial landscape. They might help researchers assess treatments in months or years instead of waiting decades for disease or mortality outcomes.
The work also reflects a shift away from treating all interventions as interchangeable. The analysis compared lifestyle patterns, prescription drugs, supplements and procedures within the exact same statistical framework. This revealed stronger and more consistent responses for some categories than others, providing a roadmap for future longevity research.
For adults over 60, the immediate application is a renewed focus on daily habits over commercial anti-aging pills. The study reinforces the value of sustainable nutrition frameworks rather than chasing single branded diets. Because Mediterranean, low-carbohydrate and low-fat patterns all showed consistent biomarker reductions with exercise, older adults have flexibility. They can choose a nutritionally adequate plan that fits their personal preferences and sustains their long-term health goals.
Physical activity should also be treated as a core component of healthy aging rather than just a weight management tool. Exercise was a consistent part of the lifestyle combination that reliably reduced epigenetic age measures. Adults can adapt their movement routines to their physical abilities and medical conditions while still supporting their biological health. Incorporating lifestyle choices that pair regular movement with quality nutrition offers a highly reliable path forward.
The Yale study did not identify one universally optimal exercise prescription for memory or cognition. This means older adults do not need to force themselves into rigid fitness programs that feel unsustainable. Physical activity should be adapted to physical ability, medical conditions and personal preferences. Consistent movement integrated into daily routine remains a foundational habit.
Adults should not substitute supplements for foundational health habits. The Yale analysis found that the tested over-the-counter supplements had little or inconsistent effect on epigenetic age. A supplement may still be appropriate for a diagnosed deficiency or a clinician-supported indication. However, the analysis does not support relying on non-prescription pills as a broad strategy to slow biological aging.
These findings center on biomarker responsiveness and do not establish that these interventions guarantee longer life or cognitive improvement. The Yale analysis did not show that a lower epigenetic age improves memory, attention or cognition. Yale explicitly stated the study did not establish that the observed changes increase lifespan. A lower reading on an epigenetic clock should be viewed as an interesting research signal rather than a personal medical guarantee.
Senior author Albert Higgins-Chen stated that the meaning of a change in an epigenetic clock remains unresolved. Researchers must still determine what these biomarker changes mean for long-term risk of age-related disease and functional decline. Sehgal also cautioned that researchers have a long way to go in understanding the biological aging process. It is still unclear whether many interventions genuinely work in the ways people hope.
Researchers still need to determine which biomarker changes are caused by an intervention and which may reflect hidden confounding factors. They also need to study how long changes persist after an intervention ends.
Other research separately links biological-aging measures with cognitive and neurological outcomes, but those findings should not be conflated with the Yale intervention analysis. For example, a 2026 study reported that proteomic aging measures explained some variation in cognitive and neurological markers not explained by epigenetic measures. This illustrates that different biological clocks capture entirely different aspects of human aging. Relying solely on epigenetic clocks paints an incomplete picture of an older adult's cognitive trajectory.
The data also showed that biomarkers changed more strongly among people with diseases than among healthy volunteers. A biomarker response observed in a medically affected population may not translate directly to a healthy older person. Older adults should not use these early epigenetic findings to make medical decisions. Furthermore, they should avoid seeking out prescription treatments like metformin or semaglutide for broad anti-aging purposes.
This biomarker research must be viewed alongside established, multi-factor risk models. The 2024 Lancet Commission framework places diet and activity within a broader set of modifiable dementia-risk factors. That framework identifies diabetes, hypertension, high cholesterol and physical inactivity as modifiable targets for intervention.
Obesity, hearing loss and social isolation also represent crucial areas requiring attention for long-term brain health. Adults must also address depression, untreated vision loss and harmful alcohol use. Finally, managing exposure to air pollution and eliminating smoking complete the comprehensive risk reduction strategy. Adults should continue to manage these cardiometabolic and environmental risks with routine medical care.
The most defensible takeaway from the Yale analysis is that practical daily habits matter more than isolated interventions. Consistently eating well and moving regularly reliably influenced markers of biological aging. Chasing over-the-counter anti-aging supplements yielded mixed results that do not justify abandoning foundational health practices. Focusing on clinical fundamentals provides the clearest route to healthy aging.
Protecting cognitive health and neuroplasticity requires a comprehensive, sustainable approach. Diet and physical activity should sit alongside quality sleep, regular medical care and active social engagement. Treating cardiometabolic risks with routine clinical supervision remains superior to relying on an epigenetic-age test for treatment direction. By focusing on these verified pillars, older adults can support their long-term mental clarity without relying on unproven claims.
Sorting through epigenetic clock studies demands clear analysis of complex biomarker data, and FitBrainLab translates this research so you can make informed decisions about your daily routine. Conflicting advice about nutrition, exercise, sleep, supplements and brain performance creates unnecessary confusion, but we deliver straightforward health information that respects your intelligence.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.
Build habits that support memory, focus and a curious, connected life.
Read the Blog
